Lidocaine/Diclofenac epolamine

利多卡因/双氯芬酸依泊胺

Report date: 2026/02/13 10:40:07

Base Information

Drug NameLidocaine/Diclofenac epolamine
Drug Alias NameVersatis LEGRT-7019
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-2 inhibitorsCyclooxygenase-1 inhibitorsSodium channels blockers
TargetsCyclooxygenase-2Cyclooxygenase-1Sodium channels
Therapy Area/IndicationsLow Back PainOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesGrunenthal Gmbh
Inactive CompaniesN/A
Active IndicationsLow Back PainOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A